Description
Product Overview / 商品概要
BIO-THREE Combined Tablets (ビオスリー配合錠)
Generic: Lactomin / Clostridium butyricum / Bacillus subtilis combination / ラクトミン・酪酸菌・糖化菌配合剤
Therapeutic Category: Live Bacterial Preparation / Clostridium butyricum Combination / 活性生菌製剤・酪酸菌配合剤
Manufactured by: Toa Pharmaceutical Co., Ltd. / 東亜薬品工業株式会社
Composition & Specification / 組成・規格
Active Ingredient: Lactomin 2mg, Clostridium butyricum 10mg, Bacillus subtilis 10mg per tablet / 1錠中 ラクトミン2mg、酪酸菌10mg、糖化菌10mg
Additives: Potato starch, Microcrystalline cellulose, Low-substituted hydroxypropylcellulose, Lactose hydrate, Hydroxypropylcellulose, Light anhydrous silicic acid, Talc, Magnesium stearate / バレイショデンプン、結晶セルロース、低置換度ヒドロキシプロピルセルロース、乳糖水和物、ヒドロキシプロピルセルロース、軽質無水ケイ酸、タルク、ステアリン酸マグネシウム
Appearance: Color: White to slightly yellowish-brown; Odor: Odorless or with a slight characteristic odor; Taste: Slightly sweet; Dosage form: Uncoated tablet; Diameter: 8mm; Thickness: 4.2mm; Weight: 200mg/tablet; Identification code: TK03
外観: 色調:白色~わずかに黄褐色、においはないか、又はわずかに特異なにおい、味:やや甘い、剤形:素錠、直径:8mm、厚さ:4.2mm、重量:200mg/錠、識別コード:TK03
Indications / 効能効果
EN: Improvement of various symptoms caused by abnormal intestinal flora
JA: 腸内菌叢の異常による諸症状の改善
Dosage and Administration / 用法用量
EN: Usually, adults take 3 to 6 tablets per day orally in 3 divided doses. The dose may be adjusted according to age and symptoms.
JA: 通常成人1日3~6錠を3回に分割経口投与する。なお、年齢、症状により適宜増減する。
Contraindications / 禁忌
EN:
JA:
Regulatory Information / 規制情報
Approval No.: 22100AMX01636000
Sales Started: September 2009 / 2009年9月
Classification Code: 872316
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年
Packaging / 包装
Main Package (for sale): 630 tablets [21 tablets (PTP) x 30] / 630錠[21錠(PTP)×30]
Other Available Packages (by special order): 630 tablets [21 tablets (PTP) x 30], 1000 tablets (bulk)
Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.




Reviews
There are no reviews yet.